2,651
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia

, , , , , & show all
Article: 2135694 | Received 20 Jun 2022, Accepted 09 Oct 2022, Published online: 25 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrew B. Song & Hanny Al-Samkari. (2023) Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Review of Hematology 16:5, pages 365-375.
Read now

Articles from other publishers (2)

Eman Mostafa Hamed, Ahmed R. N. Ibrahim, Mohamed Hussein Meabed, Ahmed M. Khalaf, Doaa Mohamed El Demerdash, Marwa O. Elgendy, Haitham Saeed, Heba F. Salem & Hoda Rabea. (2023) Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients. Pharmaceuticals 16:9, pages 1215.
Crossref
Francisco José López‐Jaime, Ihosvany Fernández‐Bello, Eva Calavia‐Aranda, Begoña Reina‐Monsó & Adrián Montaño. (2023) Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa ( rIX‐FP ): A case report . Clinical Case Reports 11:6.
Crossref